Cladocolea micrantha
Cladocolea micrantha · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cladocolea micrantha is a significant botanical species known for its diverse array of bioactive secondary metabolites. Research into its chemical profile has identified several key compounds, including the phytosterols beta-sitosterol and cycloartenol. Furthermore, the plant contains important triterpenoids such as lupeol, which contribute to its complex biological activity. The presence of gallic acid further distinguishes its phytochemical composition, offering potential medicinal interest. Understanding these specific constituents is essential for exploring the therapeutic possibilities of this unique plant.
- Synonyms
- Phthirusa Micrantha Var. Bolivariensis · Phthirusa Micrantha · 3 more
- Common names
- Not available
- Family
- Loranthaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Cladocolea micrantha is a botanical species that has been documented under several different scientific names throughout history. Taxonomic records show that this plant is frequently referred to by the synonyms Passovia micrantha and Phthirusa micrantha. It has also been identified in various studies as Phthirusa bernardiana and Struthanthus micranthus. Furthermore, specific variations of the species have been classified as Phthirusa micrantha var. bolivariensis. Understanding these shifting nomenclatures is essential for researchers tracking the evolutionary lineage of this unique plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cladocolea micrantha is a distinctive member of the kingdom Plantae. Within this vast biological kingdom, the plant is classified under the class Equisetopsida. It belongs to the specific order Santalales, reflecting its evolutionary lineage. Further refinement shows that this species is part of the genus Cladocolea. Ultimately, its botanical identity is completed by its placement within the family Loranthaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Santalales |
| Family | Loranthaceae |
| Genus | Cladocolea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cladocolea micrantha is a notable plant species with a significant presence across much of South America. Its distribution extends through various regions of Brazil, including both the northern and northeastern territories. The species is also widely found throughout Northern South America, spanning several distinct nations. Specifically, it can be identified within the lush landscapes of French Guiana, Guyana, and Suriname. This broad geographical range highlights the plant's adaptability to the diverse tropical environments of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cladocolea micrantha is characterized by its distinct growth form as an herb. This species is entirely self-supporting, allowing it to maintain its structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Cladocolea micrantha, an Amazonian medicinal mistletoe, has been found to contain a diverse array of bioactive compounds. Scientific analysis has successfully isolated several key triterpenes from the plant, including lupeol and cycloartenol. Additionally, the species is characterized by the presence of important phytosterols such as beta-sitosterol and stigmasterol. Beyond these lipids, researchers also identified the presence of gallic acid within its chemical profile. These specific constituents contribute to the complex phytochemical makeup that defines this medicinal species.
Conditions
Cladocolea micrantha contains specific chemical compounds that demonstrate a notable effect on human melanoma cells. Research into this Amazonian medicinal mistletoe identified a unique quercetin derivative with an uncommon interglycosidic linkage. While this specific derivative did not exhibit direct cytotoxicity toward MV3 human melanoma cells, it played a significant role in regulating cell behavior. When administered at a concentration of 1 microg/mL, the compound successfully promoted a twofold inhibition of melanoma cell migration. This inhibitory effect was remarkably effective, even when compared to the performance of paclitaxel at 5 uM in a transwell system.